Ads
related to: leukemia in elderly patients- AML Information
Read More Information About
mIDH1 & Acute Myeloid Leukemia.
- FAQ Page
Additional Questions? Visit Our FAQ
Page For More Information.
- Dosing & Management
Learn About Dosing For R/R mIDH1
Acute Myeloid Leukemia.
- Connect with a Rep
Schedule an Appointment with
A Representative Today
- Test To Target mIDH1
Learn How To Test To Target IDH1
Mutations In Your Patients With AML
- Efficacy Information
Learn About The Efficacy Of This
AML Treatment Option.
- AML Information
Search results
Results From The WOW.Com Content Network
Chronic lymphocytic leukemia (CLL) is a type of cancer that affects the blood and bone marrow. [8] [9] In CLL, the bone marrow makes too many lymphocytes, which are a type of white blood cell. [8] [9] In patients with CLL, B cell lymphocytes can begin to collect in their blood, spleen, lymph nodes, and bone marrow.
Whereas acute leukemia must be treated immediately, chronic forms are sometimes monitored for some time before treatment to ensure maximum effectiveness of therapy. Chronic leukemia mostly occurs in older people but can occur in any age group. Additionally, the diseases are subdivided according to which kind of blood cell is affected.
Acute erythroid leukemia is rare, accounting for only 3–5% of all acute myeloid leukemia cases. [2] One study estimated an occurrence rate of 0.077 cases per 100,000 people each year. [ 12 ] 64–70% of people with this condition are male, and most are elderly, with a median age of 65.
Non-Hodgkin’s lymphoma (NHL) is one of the most common forms of blood cancer.1 The American Cancer Society estimates that about 81,560 people in the U.S. will be diagnosed with NHL and about ...
B-PLL represents less than 1% of all leukemia cases worldwide, [28] mainly affecting the elderly population with a mean age of presentation between 65 and 70 [29] years. Most cases have shown slight male predominance, with a male-to-female ratio of 1.6 to 1, [28] and the vast majority of patients being Caucasians. [5]
Generally older patients over 60 have a poor outlook due to prior health status before the diagnosis and the aggressive chemotherapy regimen used. [13] The aggressive chemotherapy regimen can lead to long-term side effects such as prolonged anemia, leukocytopenia, neutropenia, and thrombocytopenia. [11]
Ad
related to: leukemia in elderly patients